(Q34550326)
Statements
Dramatic response to dabrafenib and trametinib combination in a BRAF V600E-mutated cholangiocarcinoma: implementation of a molecular tumour board and next-generation sequencing for personalized medicine (English)
Erica Clayton
Emma Furth
Mark O'Hara
Jennifer Morrissette
6 November 2014
1 reference
1 reference
1 reference